Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study
Figure 1
Distant metastasis-free survival, DMFS, in months, according to CTC detection before neoadjuvant chemotherapy ((a), ) or after neoadjuvant chemotherapy ((b), ). Black lines correspond to patients with ≥1 CTC/7.5 mL and grey lines to patients with no CTC detected.
